NEW YORK, Aug. 12 - Andrew Whiteley's first day as CEO of InforMax, on April 1, happened also to be the first day of the company's fiscal second quarter. Three months later, after laying off 15 percent of its staff, InforMax went on to post barely $4 million in receipts--a 50-percent drop from last year's second quarter--and book $6.5 million in net losses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.